Zobrazeno 1 - 10
of 189
pro vyhledávání: '"R. Rottiers"'
Autor:
R. Rottiers, Galina Khorosheva, Bart Keymeulen, Corinne Debroye, Ursule Van de Velde, Joeri Jan Pen, André Huyghebaert
Publikováno v:
Clinical nutrition ESPEN. 23
Summary Background & aims Sweetening agents are sugar substitutes with a low glycemic index, used to obtain a better glycemic control in diabetes patients. However, they also may have a role in other subjects, as a high glycemic index is thought to c
Autor:
Guy E.H.M. Rutten, K. M. Shaw, Anna Novials, A. Grimaldi, G. Schernthaner, R. Rottiers, J. Drzewoski, M. Kvapil, U. Di Mario, P. Kempler
Publikováno v:
European Journal of Clinical Investigation. 34:535-542
Background Progressive β-cell failure is a characteristic feature of type 2 diabetes; consequently, β-cell secretagogues are useful for achieving sufficient glycaemic control. The European GUIDE study is the first large-scale head-to-head compariso
Autor:
R. Rottiers
Publikováno v:
Acta Clinica Belgica. 58:269-276
(2003). NEW CLASSIFICATION AND NEW DIAGNOSTIC CRITERIA OF DIABETES MELLITUS. Acta Clinica Belgica: Vol. 58, No. 5, pp. 269-276.
Autor:
Anne Katrin Sjølie, Judith Stephenson, Steve Aldington, Eva Kohner, Hans Janka, Lynda Stevens, John Fuller, B. Karamanos, C. Tountas, A. Kofinis, K. Petrou, N. Katsilambros, M. Cignarelli, R. Giorgino, M.L. De Geco, I. Ramunni, C. Ionescu-Tirgoviste, C.M. Iosif, C. Pitei, S. Buligescu, G. Tamas, Z. Kerenyi, A.M. Ahmed, J. Toth, P. Kempler, S. Muntoni, M. Songini, M. Stabilini, M. Fossarello, S. Pintus, B. Ferriss, C.C. Cronin, M. Toeller, A. Klischan, T. Forst, F.A. Gries, R. Rottiers, H. Priem, P. Ebeling, M. Sinisalo, V.A. Koivisto, B. Idzior-Walus, B. Solnica, L. Szopinska-Ciba, K. Solnica, H.M.J. Krans, H.H.P.J. Lemkes, J.J. Jansen, J. Nunes-Cornea, J. Boavida, G. Michel, R. Wirion, A.J.M. Boulton, H. Ashe, D.J.S. Fernando, G. Pozza, G. Slaviero, G. Comi, B. Fattor, F. Bandello, H. Mehnert, A. Nuber, H. Janka, D. Ben Soussan, M.C. Fallas, P. Fallas, E. Jepson, S. McHardy-Young, J.H. Fuller, D.J. Betteridge, M. Milne, G. Crepaldi, R. Nosadini, G. Cathelineau, B. Villatte Cathelineau, M. Jellal, N. Grodner, P. Gervais Feiss, F. Santeusanio, G. Rosi, M.R.M. Ventura, C. Cagini, C. Marino, R. Navalesi, G. Penno, R. Miccoli, M. Nannipieri, S. Manfredi, G. Ghirlanda, P. Cotroneo, A. Manto, C. Teodonio, A. Minnella, J.D. Ward, S. Tesfaye, C. Mody, C. Rudd, G.M. Molinatti, F. Vitelli, M. Porta, G.F. Pagano, P. Cavallo Perin, P. Estivi, R. Sivieri, Q. Carta, G. Petraroli, N. Papazoglou, G. Manes, G. Triantaphyllou, A. Ioannides, M. Muggeo, V. Cacciatori, F. Bellavere, P. Galante, M.L. Gemma, K. Irsigler, H. Abrahamian, C. Gurdet, B. Hornlein, C. Willinger, S. Walford, E.V. Wardle, G. Roglic, Z. Resman, Z. Metelko, Z. Skrabalo
Publikováno v:
Ophthalmology. 104:252-260
Purpose: To assess the frequency of retinopathy and vision loss in patients with insulin-dependent diabetes mellitus and their relations to potentially modifiable risk factors. Methods: The authors conducted a multicenter cross-sectional study of dia
Autor:
Alexandre Persu, Christian Brohet, G. Vanhooren, F.R. Heller, Jean-Marie Krzesinski, W. Van Mieghem, A. G. Dupont, R. Rottiers, Luc Pierard, Luc Missault, M.-D. Gazagnes, A. G. Herman, J.-M. Billiouw, P. Vervaet
Publikováno v:
Acta clinica Belgica
Europe PubMed Central
Vrije Universiteit Brussel
Europe PubMed Central
Vrije Universiteit Brussel
The HOPE and EUROPA clinical studies have shown that treatment with the angiotensin-converting enzyme (ACE) inhibitors, ramipril and perindopril, may reduce the occurrence of major cardiovascular events in patients with proven atherosclerotic disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a21f060ed40b04d943c5702ff479b63c
https://hdl.handle.net/20.500.14017/a88cfb81-7863-465f-a85f-4cb16641ff66
https://hdl.handle.net/20.500.14017/a88cfb81-7863-465f-a85f-4cb16641ff66
Autor:
P Decraene, E Muls, P Vanrooy, D Vangeermersch, Robert Rubens, I Deleeuw, R Bouillon, W Vandesompel, Jean Delaey, Hildegaard Priem, Anita Leys, C Devuyst, J Bekaert, Herman Steyaert, R. Rottiers
Publikováno v:
Ophthalmologica. 204:4-12
In this multicentre double-blind study, 100 insulin-treated diabetics with background retinopathy were randomly assigned to treatment with either 250 mg ticlopidine b.i.d. (49 patients) or placebo (51
Autor:
P. Vervaet, A. G. Dupont, G. Vanhooren, F.R. Heller, Alexandre Persu, J.-M. Billiouw, Luc Pierard, A. G. Herman, V. Berlaimont, W. Van Mieghem, Luc Missault, R. Rottiers, Jean-Marie Krzesinski, M.-D. Gazagnes, Christian Brohet
Publikováno v:
ResearcherID
Vrije Universiteit Brussel
Acta clinica Belgica
Vrije Universiteit Brussel
Acta clinica Belgica
The recently published results of the ONTARGET trial shed a new light on the cardiovascular protection of patients at high risk of a cardiovascular event. Despite a number of trials looking at the efficacy of Angiotensin Converting Enzyme inhibitors
Autor:
I. Truyen, F. K. Gorus, Bart Keymeulen, Daniel Pipeleers, Chantal Mathieu, K. Decochez, Belgian Diabetes Registry, B. Van der Auwera, I. De Leeuw, E. Vandemeulebroucke, R. Rottiers, I Weets
Publikováno v:
Diabetologia
Vrije Universiteit Brussel
Vrije Universiteit Brussel
Aims/hypothesis: Prevention trials in first-degree relatives of type 1 diabetic patients are hampered by large interindividual differences in progression rate to diabetes. We investigated whether specific combinations of immune and genetic markers ca
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 18(4)
To determine whether circulating plasma vascular endothelial growth factor (VEGF) is elevated in the presence of diabetic microvascular complications, and whether the impact of angiotensin-converting enzyme (ACE) inhibitors on these complications can
Autor:
I. Weets, J. Van Autreve, B. J. Van der Auwera, F. C. Schuit, M. V. L. Du Caju, K. Decochez, I. H. De Leeuw, B. Keymeulen, C. Mathieu, R. Rottiers, H. Dorchy, E. Quartier, F. K. Gorus, the Belgian Diabetes Registry
Publikováno v:
Diabetologia
Aims/hypothesis. We investigated whether the reported HLA-DQ/DR restricted male-to-female (M:F) excess in Type I (insulin-dependent) diabetes mellitus also exists in Belgian patients, is specific for immune-mediated diabetes, remains genotype-restric